Introduction to artificial cells: concept, history, design, current status and future - Artificial Cells, Cell Engineering and Therapy - page 37

110. Uludag H, de Vos P, Tresco PA. Technology of mammalian cell encapsulation.
Advanced Drug Delivery Reviews 2000; 42(1±2):29±64.
111. Chen HM, Wei OY, Bisi LY, Martoni C, Prakash S. Reaction of chitosan with
genipin and its fluorogenic attributes for potential microcapsule membrane
characterization. Journal of Biomedical Materials Research Part A 2005;
75A(4):917±927.
112. King A. Evaluation of Alginate Microcapsules for Use in Transplantation of Islets
of Langerhans. University of Uppsala, 2001.
113. Gerbsch N, Buchholz R. New processes and actual trends in biotechnology. FEMS
Microbiology Reviews 1995; 16(2±3):259±269.
114. Gombotz WR, Wee SF. Protein release from alginate matrices. Advanced Drug
Delivery Reviews 1998; 31(3):267±285.
115. Stokke BT, Smidsrod O, Bruheim P, Skjakbraek G. Distribution of uronate residues
in alginate chains in relation to alginate gelling properties. Macromolecules 1991;
24(16):4637±4645.
116. Zhang WJ. Purity of alginate affects the viability and fibrotic overgrowth of
encapsulated porcine islet xenografts. Transplantation Proceedings 2001; 33(7±
8):3517±3519.
117. Strand BL, Ryan L, Veld PI, Kulseng B, Rokstad AM, Skjak-Braek G et al. Poly- L -
lysine induces fibrosis on alginate microcapsules via the induction of cytokines.
Cell Transplantation 2001; 10(3):263±275.
118. Orive G, Carcaboso AM, Hernandez RM, Gascon AR, Pedraz JL. Biocompatibility
evaluation of different alginates and alginate-based microcapsules.
Biomacromolecules 2005; 6(2):927±931.
119. de Vos P, Hoogmoed CG, Busscher HJ. Chemistry and biocompatibility of
alginate±PLL capsules for immunoprotection of mammalian cells. Journal of
Biomedical Materials Research 2002; 60(2):252±259.
120. de Vos P, van Hoogmoed CG, De Haan BJ, Busscher HJ. Tissue responses against
immunoisolating alginate±PLL capsules in the immediate posttransplant period.
Journal of Biomedical Materials Research 2002; 62(3):430±437.
121. Cui JH, Goh JS, Kim PH, Choi SH, Lee BJ. Survival and stability of bifidobacteria
loaded in alginate poly- L -lysine microparticles. International Journal of

Pharmaceutics 2000; 210(1±2):51±59.
122. Chen H, Ouyang W, Jones M, Haque T, Lawuyi B, Prakash S. In-vitro analysis of
APA microcapsules for oral delivery of live bacterial cells. Journal of

Microencapsulation 2005; 22(5):539±547.
123. Tam SK, Dusseault J, Polizu S, Menard M, Halle JP, Yahia L. Physicochemical
model of alginate±poly- L -lysine microcapsules defined at the micrometric/
nanometric scale using ATR-FTIR, XPS, and ToF-SIMS. Biomaterials 2005;
26(34):6950±6961.
124. Bucko M. Immobilization of a whole-cell epoxide-hydrolyzing biocatalyst in
sodium alginate±cellulose sulfate±poly(methylene-co-guanidine) capsules using a
controlled encapsulation process. Enzyme and Microbial Technology 2005;
36(1):118±126.
125. Orive G, Hernandez RM, Gascon AR, Igartua M, Pedraz JL. Development and
optimisation of alginate±PMCG±alginate microcapsules for cell immobilisation.
International Journal of Pharmaceutics 2003; 259(1±2):57±68.
126. Sodini I, Boquien CY, Corrieu G, Lacroix C. Use of an immobilized cell bioreactor
for the continuous inoculation of milk in fresh cheese manufacturing. Journal of
Industrial Microbiology & Biotechnology 1997; 18(1):56±61.